[NFS-02] Neuroscience Frontier Symposium 02

[NFS-02-3] Pathological distinction of CBD and PSP:possible and meaningful?

^○Toshiki Uchihara^1,2,3 (1.Nitobe Memorial Nakano General Hospital, Neurology Clinic with Neuromophomics Laboratory, Japan, 2.Tokyo Medical and Dental University, Neurology and Neurlogical Science, Japan, 3.Juntendo University, Neurology, Japan)